SR

Shivani Ravi Atole

Active Director Director DIN 10232165
DIN 10232165 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Shivani Ravi Atole

Data last updated:

Shivani Ravi Atole is a Director at Hardyz Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Hardyz Pharmaceuticals Private Limited reported revenue of ₹22.3 Lakh (FY 2025).

DIN 10232165
Primary Designation Director
Industry Pharma
First Appointment 10 Jul 2023
Oldest Company Age 3 yrs
Largest company Hardyz Pharmaceuticals Private Limited · ₹22.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jul 20232023₹22.3 Lakh (FY 2025)Active

Board colleagues of Shivani Ravi Atole

NameDINCompanyDesignation
Ravi Narayan Atole09795107Hardyz Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hardyz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shivani Ravi Atole

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivani Ravi Atole

Shivani Ravi Atole currently holds 1 directorship: Hardyz Pharmaceuticals Private Limited (Director, since 10 Jul 2023, revenue ₹22.3 Lakh (FY 2025)).

Shivani Ravi Atole was first appointed on 10 Jul 2023 as Director at Hardyz Pharmaceuticals Private Limited.

The current boards of Shivani Ravi Atole's companies include Ravi Narayan Atole (Hardyz Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available